Tuesday to advance $1 million for a new diabetes care program amid questions about the funding source and its sustainability.

Several factors have led to a pediatric endocrinologist shortage in the U.S. that has caused large care gaps for children, ...

Five weeks after the FDA approved a pill that extends survival in metastatic pancreatic cancer, one of the physicians who led ...

Safe completion of the first dose cohort in which QEL-005 was well tolerated, with no dose-limiting toxicities (DLTs), no treatment-related ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

PRNewswire/ -- ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies ...

Endo-TAGSS is the first percutaneous intragastric trocar that enables minimally invasive pyloroplasty for patients who don’t respond to prokinetic and antiemetic medications.

Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after ...

Rising diabetes prevalence, about 724,000 diagnosed US cases in 2025, and late-stage candidates naronapride and deudomperidone (CIN-102) drive growth across the US, EU4, UK and Japan.Dublin, Oct. 21, ...

The FDA and Department of Health and Human Services have to deliver. No American should have to buy a plane ticket to London ...

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a nutritional supplement ...